This opportunity is no longer accepting applications.
grant PAR-23-056

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

This grant is aimed at supporting research on how multiple infections contribute to cancer development, with a focus on improving prevention and treatment strategies for cancers related to infections. It seeks studies on co-infections, involving two or more infectious agents, whether they happen at the same time or one after the other. These infections can be from viruses, bacteria, parasites,…

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infect…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: December 14, 2022
Open for Submission: December 14, 2022
Submission Deadline: November 16, 2025
Application Window Closes: November 16, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.